Müller-Tasch Thomas, Frankenstein Lutz, Holzapfel Nicole, Schellberg Dieter, Löwe Bernd, Nelles Manfred, Zugck Christian, Katus Hugo, Rauch Bernhard, Haass Markus, Jünger Jana, Remppis Andrew, Herzog Wolfgang
Department of Psychosomatic and General Internal Medicine, University of Heidelberg, Heidelberg, Germany.
J Psychosom Res. 2008 Mar;64(3):299-303. doi: 10.1016/j.jpsychores.2007.09.002.
Our objective was to assess the prevalence of panic disorder, its influence on quality of life (QoL), and the presence of further anxiety and depressive comorbid disorders in outpatients with chronic heart failure (CHF).
In a cross-sectional study, anxiety and depressive disorders were diagnosed according to Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition diagnostic criteria in patients with CHF who were aged > or =18 years and had New York Heart Association (NYHA) Functional Classes I-IV, using the Patient Health Questionnaire. Health-related QoL was evaluated using the Short-Form 36 Health Survey (SF-36).
Of the 258 participating patients, 24 (9.3%) fulfilled diagnostic criteria for panic disorder. Seven of these (29.2%) were diagnosed with comorbid anxiety disorders, 11 (47.3%) were diagnosed with comorbid depressive disorder, and 5 (20.8%) were diagnosed with other anxiety disorders and any depressive disorder. Female gender [odds ratio (OR)=3.1; 95% confidence interval (95% CI)=1.2-7.8; P=.02] and a lower level of education (OR=0.3; 95% CI=0.1-0.9; P=.04) were associated with the presence of panic disorder. In patients with panic disorder, QoL was significantly more restricted on all subscales of the SF-36 as compared to those without panic disorder, even when age, gender, and NYHA functional class were controlled for (P=.05 to <.01).
Approximately 1 of 10 patients with CHF suffers from panic disorder, many of whom also have additional anxiety or depressive comorbid disorders. Female gender and a low level of education are positively associated with the presence of panic disorder. QoL is severely limited by the presence of panic disorder. Diagnosis of mental disorders and treatment offers for affected patients should be available in patient care.
我们的目的是评估慢性心力衰竭(CHF)门诊患者中惊恐障碍的患病率、其对生活质量(QoL)的影响以及是否存在其他焦虑和抑郁共病障碍。
在一项横断面研究中,根据《精神疾病诊断与统计手册》第四版诊断标准,使用患者健康问卷对年龄≥18岁、纽约心脏协会(NYHA)心功能分级为I-IV级的CHF患者进行焦虑和抑郁障碍的诊断。使用简短健康调查问卷(SF-36)评估与健康相关的生活质量。
在258名参与研究的患者中,24名(9.3%)符合惊恐障碍的诊断标准。其中7名(29.2%)被诊断为合并焦虑障碍,11名(47.3%)被诊断为合并抑郁障碍,5名(20.8%)被诊断为其他焦虑障碍和任何抑郁障碍。女性[比值比(OR)=3.1;95%置信区间(95%CI)=1.2-7.8;P=0.02]和较低的教育水平(OR=0.3;95%CI=0.1-0.9;P=0.04)与惊恐障碍的存在相关。与无惊恐障碍的患者相比,即使在控制了年龄、性别和NYHA心功能分级后,有惊恐障碍的患者在SF-36的所有子量表上的生活质量也受到更显著的限制(P=0.05至<0.01)。
约十分之一的CHF患者患有惊恐障碍,其中许多人还患有其他焦虑或抑郁共病障碍。女性和低教育水平与惊恐障碍的存在呈正相关。惊恐障碍的存在严重限制了生活质量。在患者护理中应提供对受影响患者的精神障碍诊断和治疗。